In vitro induction of erythrocyte phosphatidylserine translocation by the natural naphthoquinone shikonin

Toxins

Volumn 6, Issue 5, 2014, Pages 1559-1574

  Lupescu, Adrian ^a   Bissinger, Rosi ^a   Jilani, Kashif ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Calcium; Cell volume; Ceramide; Eryptosis; Phosphatidylserine; Shikonin

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; CERAMIDE; FLUO 3; PHOSPHATIDYLSERINE; SHIKONIN; CALCIUM; NAPHTHOQUINONE;

ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE VOLUME; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEMOLYSIS; HUMAN; HUMAN CELL; BLOOD; DRUG EFFECTS; IN VITRO STUDY; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ADENOSINE TRIPHOSPHATE; BIOLOGICAL TRANSPORT; CALCIUM; ERYTHROCYTES; HUMANS; IN VITRO TECHNIQUES; NAPHTHOQUINONES; PHOSPHATIDYLSERINES;

EID: 84901218342     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins6051559     Document Type: Article

References (93)

1. Andujar, I.; Rios, J.L.; Giner, R.M.; Recio, M.C. Pharmacological properties of shikonin-A review of literature since 2002. Planta Med. 2013, 79, 1685-1697.
2. Chen, X.; Yang, L.; Oppenheim, J.J.; Howard, O.M.Z. Cellular pharmacology studies of shikonin derivatives. Phytother. Res. 2002, 16, 199-209.
3. Lu, L.; Qin, A.; Huang, H.; Zhou, P.; Zhang, C.; Liu, N.; Li, S.; Wen, G.; Zhang, C.; Dong, W. et al. Shikonin extracted from medicinal chinese herbs exerts anti-inflammatory effect via proteasome inhibition. Eur. J. Pharmacol. 2011, 658, 242-247.
4. Gao, H.; Liu, L.; Qu, Z.Y.; Wei, F.X.; Wang, S.Q.; Chen, G.A.; Qin, L.; Jiang, F.Y.; Wang, Y.C.; Shang, L. et al. Anti-adenovirus activities of shikonin, a component of chinese herbal medicine in vitro. Biol. Pharm. Bull. 2011, 34, 197-202.
5. Andujar, I.; Rios, J.L.; Giner, R.M.; Recio, M.C. Shikonin promotes intestinal wound healing in vitro via induction of tgf-beta release in iec-18 cells. Eur. J. Pharm. Sci. 2013, 49, 637-641.
6. Chen, H.M.; Wang, P.H.; Chen, S.S.; Wen, C.C.; Chen, Y.H.; Yang, W.C.; Yang, N.S. Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Cancer Immunol. Immunother. 2012, 61, 1989-2002.
7. Wang, Y.; Zhou, Y.; Jia, G.; Han, B.; Liu, J.; Teng, Y.; Lv, J.; Song, Z.; Li, Y.; Ji, L. et al. Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of nf-kappab signaling pathway. Biochem. Pharmacol. 2014, 88, 322-333.
8. Wang, R.; Yin, R.; Zhou, W.; Xu, D.; Li, S. Shikonin and its derivatives: A patent review. Expert Opin. Ther. Pat. 2012, 22, 977-997.
9. Chen, C.H.; Lin, M.L.; Ong, P.L.; Yang, J.T. Novel multiple apoptotic mechanism of shikonin in human glioma cells. Ann. Surg. Oncol. 2012, 19, 3097-3106.
10. Han, W.; Li, L.; Qiu, S.; Lu, Q.; Pan, Q.; Gu, Y.; Luo, J.; Hu, X. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol. Cancer Ther. 2007, 6, 1641-1649.
11. Hou, Y.; Guo, T.; Wu, C.; He, X.; Zhao, M. Effect of shikonin on human breast cancer cells proliferation and apoptosis in vitro. J. Pharm. Soc. Jap. 2006, 126, 1383-1386.
12. Huang, C.J.; Luo, Y.A.; Zhao, J.W.; Yang, F.W.; Zhao, H.W.; Fan, W.H.; Ge, P.F. Shikonin kills glioma cells through necroptosis mediated by rip-1. PLoS ONE 2013, 8. e66326.
13. Liu, C.; Yin, L.; Chen, J.; Chen, J. The apoptotic effect of shikonin on human papillary thyroid carcinoma cells through mitochondrial pathway. Tumour. Biol. 2013, 35, 1791-1798.
14. Park, S.; Shin, H.; Cho, Y. Shikonin induces programmed necrosis-like cell death through the formation of receptor interacting protein 1 and 3 complex. Food Chem. Toxicol. 2013, 55, 36-41.
15. Piao, J.L.; Cui, Z.G.; Furusawa, Y.; Ahmed, K.; Rehman, M.U.; Tabuchi, Y.; Kadowaki, M.; Kondo, T. The molecular mechanisms and gene expression profiling for shikonin-induced apoptotic and necroptotic cell death in u937 cells. Chem. Biol. Interact. 2013, 205, 119-127.
16. Yingkun, N.; Lvsong, Z.; Huimin, Y. Shikonin inhibits the proliferation and induces the apoptosis of human hepg2 cells. Can. J. Physiol. Pharmacol. 2010, 88, 1138-1146.
17. Zhang, F.L.; Wang, P.; Liu, Y.H.; Liu, L.B.; Liu, X.B.; Li, Z.; Xue, Y.X. Topoisomerase inhibitors, shikonin and topotecan, inhibit growth and induce apoptosis of glioma cells and glioma stem cells. PLoS ONE 2013, 8, e81815.
18. Ahn, J.; Won, M.; Choi, J.H.; Kim, Y.S.; Jung, C.R.; Im, D.S.; Kyun, M.L.; Lee, K.; Song, K.B.; Chung, K.S. Reactive oxygen species-mediated activation of the akt/ask1/p38 signaling cascade and p21(cip1) downregulation are required for shikonin-induced apoptosis. Apoptosis 2013, 18, 870-881.
19. Chang, I.C.; Huang, Y.J.; Chiang, T.I.; Yeh, C.W.; Hsu, L.S. Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells. Biol. Pharm. Bull. 2010, 33, 816-824.
20. Chen, C.H.; Chern, C.L.; Lin, C.C.; Lu, F.J.; Shih, M.K.; Hsieh, P.Y.; Liu, T.Z. Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human sk-hep-1 hepatoma cells by shikonin. Planta Med. 2003, 69, 1119-1124.
21. Gong, K.; Li, W. Shikonin, a chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma. Free Radic. Biol. Med. 2011, 51, 2259-2271.
22. Lee, M.J.; Kao, S.H.; Hunag, J.E.; Sheu, G.T.; Yeh, C.W.; Hseu, Y.C.; Wang, C.J.; Hsu, L.S. Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species. Chem. Biol. Interact. 2014, 211C, 44-53.
23. Mao, X.; Yu, C.R.; Li, W.H.; Li, W.X. Induction of apoptosis by shikonin through a ros/jnk-mediated process in bcr/abl-positive chronic myelogenous leukemia (cml) cells. Cell. Res. 2008, 18, 879-888.
24. Yeh, C.C.; Kuo, H.M.; Li, T.M.; Lin, J.P.; Yu, F.S.; Lu, H.F.; Chung, J.G.; Yang, J.S. Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (t24). In Vivo 2007, 21, 1011-1019.
25. Lang, E.; Qadri, S.M.; Lang, F. Killing me softly-Suicidal erythrocyte death. Int. J. Biochem. Cell. Biol. 2012, 44, 1236-1243.
26. Lang, P.A.; Kaiser, S.; Myssina, S.; Wieder, T.; Lang, F.; Huber, S.M. Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am. J. Physiol. Cell. Physiol. 2003, 285, C1553-C1560.
27. Bhavsar, S.K.; Bobbala, D.; Xuan, N.T.; Foller, M.; Lang, F. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell. Physiol. Biochem. 2010, 26, 859-868.
28. Foller, M.; Huber, S.M.; Lang, F. Erythrocyte programmed cell death. IUBMB Life 2008, 60, 661-668.
29. Foller, M.; Mahmud, H.; Gu, S.; Wang, K.; Floride, E.; Kucherenko, Y.; Luik, S.; Laufer, S.; Lang, F. Participation of leukotriene c(4) in the regulation of suicidal erythrocyte death. J. Physiol. Pharmacol. 2009, 60, 135-143.
30. Lau, I.P.; Chen, H.; Wang, J.; Ong, H.C.; Leung, K.C.; Ho, H.P.; Kong, S.K. In vitro effect of ctab- and peg-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012, 6, 847-856.
31. Maellaro, E.; Leoncini, S.; Moretti, D.; Del Bello, B.; Tanganelli, I.; De Felice, C.; Ciccoli, L. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol. 2013, 50, 489-495.
32. Foller, M.; Sopjani, M.; Koka, S.; Gu, S.; Mahmud, H.; Wang, K.; Floride, E.; Schleicher, E.; Schulz, E.; Munzel, T. et al. Regulation of erythrocyte survival by amp-activated protein kinase. FASEB J. 2009, 23, 1072-1080.
33. Kucherenko, Y.; Zelenak, C.; Eberhard, M.; Qadri, S.M.; Lang, F. Effect of casein kinase 1alpha activator pyrvinium pamoate on erythrocyte ion channels. Cell. Physiol. Biochem. 2012, 30, 407-417.
34. Zelenak, C.; Eberhard, M.; Jilani, K.; Qadri, S.M.; Macek, B.; Lang, F. Protein kinase ck1alpha regulates erythrocyte survival. Cell. Physiol. Biochem. 2012, 29, 171-180.
35. Foller, M.; Feil, S.; Ghoreschi, K.; Koka, S.; Gerling, A.; Thunemann, M.; Hofmann, F.; Schuler, B.; Vogel, J.; Pichler, B. et al. Anemia and splenomegaly in cgki-deficient mice. Proc. Natl. Acad. Sci. USA 2008, 105, 6771-6776.
36. Bhavsar, S.K.; Gu, S.; Bobbala, D.; Lang, F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell. Physiol. Biochem. 2011, 27, 547-556.
37. Klarl, B.A.; Lang, P.A.; Kempe, D.S.; Niemoeller, O.M.; Akel, A.; Sobiesiak, M.; Eisele, K.; Podolski, M.; Huber, S.M.; Wieder, T. et al. Protein kinase c mediates erythrocyte "programmed cell death" following glucose depletion. Am. J. Physiol. Cell. Physiol. 2006, 290, C244-C253.
38. Gatidis, S.; Zelenak, C.; Fajol, A.; Lang, E.; Jilani, K.; Michael, D.; Qadri, S.M.; Lang, F. P38 mapk activation and function following osmotic shock of erythrocytes. Cell. Physiol. Biochem. 2011, 28, 1279-1286.
39. Zelenak, C.; Foller, M.; Velic, A.; Krug, K.; Qadri, S.M.; Viollet, B.; Lang, F.; Macek, B. Proteome analysis of erythrocytes lacking amp-activated protein kinase reveals a role of pak2 kinase in eryptosis. J. Proteome Res. 2011, 10, 1690-1697.
40. Lupescu, A.; Shaik, N.; Jilani, K.; Zelenak, C.; Lang, E.; Pasham, V.; Zbidah, M.; Plate, A.; Bitzer, M.; Foller, M. et al. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: An in vivo and in vitro study. Cell. Physiol. Biochem. 2012, 30, 876-888.
41. Shaik, N.; Lupescu, A.; Lang, F. Sunitinib-sensitive suicidal erythrocyte death. Cell. Physiol. Biochem. 2012, 30, 512-522.
42. Abed, M.; Towhid, S.T.; Mia, S.; Pakladok, T.; Alesutan, I.; Borst, O.; Gawaz, M.; Gulbins, E.; Lang, F. Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am. J. Physiol. Cell. Physiol. 2012, 303, C991-C999.
43. Bottger, E.; Multhoff, G.; Kun, J.F.; Esen, M. Plasmodium falciparum-infected erythrocytes induce granzyme b by nk cells through expression of host-hsp70. PLoS ONE 2012, 7, e33774.
44. Firat, U.; Kaya, S.; Cim, A.; Buyukbayram, H.; Gokalp, O.; Dal, M.S.; Tamer, M.N. Increased caspase-3 immunoreactivity of erythrocytes in stz diabetic rats. Exp. Diabetes Res. 2012, 2012, doi:10.1155/2012/316384.
45. Ganesan, S.; Chaurasiya, N.D.; Sahu, R.; Walker, L.A.; Tekwani, B.L. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: Evaluation of eryptotic pathway. Toxicology 2012, 294, 54-60.
46. Gao, M.; Cheung, K.L.; Lau, I.P.; Yu, W.S.; Fung, K.P.; Yu, B.; Loo, J.F.; Kong, S.K. Polyphyllin d induces apoptosis in human erythrocytes through Ca(2)(+) rise and membrane permeabilization. Arch. Toxicol. 2012, 86, 741-752.
47. Ghashghaeinia, M.; Cluitmans, J.C.; Akel, A.; Dreischer, P.; Toulany, M.; Koberle, M.; Skabytska, Y.; Saki, M.; Biedermann, T.; Duszenko, M. et al. The impact of erythrocyte age on eryptosis. Br. J. Haematol. 2012, 157, 606-614.
48. Jilani, K.; Lupescu, A.; Zbidah, M.; Abed, M.; Shaik, N.; Lang, F. Enhanced apoptotic death of erythrocytes induced by the mycotoxin ochratoxin A. Kidney Blood Press Res. 2012, 36, 107-118.
49. Jilani, K.; Lupescu, A.; Zbidah, M.; Shaik, N.; Lang, F. Withaferin a-stimulated Ca2+ entry, ceramide formation and suicidal death of erythrocytes. Toxicol. In Vitro 2013, 27, 52-58.
50. Kucherenko, Y.V.; Lang, F. Inhibitory effect of furosemide on non-selective voltage-independent cation channels in human erythrocytes. Cell. Physiol. Biochem. 2012, 30, 863-875.
51. Lang, E.; Qadri, S.M.; Jilani, K.; Zelenak, C.; Lupescu, A.; Schleicher, E.; Lang, F. Carbon monoxide-sensitive apoptotic death of erythrocytes. Basic Clin. Pharmacol. Toxicol. 2012, 111, 348-355.
52. Polak-Jonkisz, D.; Purzyc, L. Ca influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif. 2012, 34, 209-210.
53. Qian, E.W.; Ge, D.T.; Kong, S.K. Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J. Nat. Prod. 2012, 75, 531-537.
54. Shaik, N.; Zbidah, M.; Lang, F. Inhibition of Ca(2+) entry and suicidal erythrocyte death by naringin. Cell. Physiol. Biochem. 2012, 30, 678-686.
55. Vota, D.M.; Maltaneri, R.E.; Wenker, S.D.; Nesse, A.B.; Vittori, D.C. Differential erythropoietin action upon cells induced to eryptosis by different agents. Cell. Biochem. Biophys. 2013, 65, 145-157.
56. Weiss, E.; Cytlak, U.M.; Rees, D.C.; Osei, A.; Gibson, J.S. Deoxygenation-induced and Ca(2+) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell. Calcium 2012, 51, 51-56.
57. Zappulla, D. Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: Adaptations to CO2 increases? J. Cardiometab. Syndr. 2008, 3, 30-34.
58. Zbidah, M.; Lupescu, A.; Jilani, K.; Lang, F. Stimulation of suicidal erythrocyte death by fumagillin. Basic Clin. Pharmacol. Toxicol. 2013, 112, 346-351.
59. Zelenak, C.; Pasham, V.; Jilani, K.; Tripodi, P.M.; Rosaclerio, L.; Pathare, G.; Lupescu, A.; Faggio, C.; Qadri, S.M.; Lang, F. Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure. Cell. Physiol. Biochem. 2012, 30, 282-294.
60. Abed, M.; Herrmann, T.; Alzoubi, K.; Pakladok, T.; Lang, F. Tannic acid induced suicidal erythrocyte death. Cell. Physiol. Biochem. 2013, 32, 1106-1116.
61. Ahmed, M.S.; Langer, H.; Abed, M.; Voelkl, J.; Lang, F. The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res. 2013, 37, 158-167.
62. Ghashghaeinia, M.; Cluitmans, J.C.; Toulany, M.; Saki, M.; Koberle, M.; Lang, E.; Dreischer, P.; Biedermann, T.; Duszenko, M.; Lang, F. et al. Age sensitivity of nfkappab abundance and programmed cell death in erythrocytes induced by nfkappab inhibitors. Cell. Physiol. Biochem. 2013, 32, 801-813.
63. Abed, M.; Feger, M.; Alzoubi, K.; Pakladok, T.; Frauenfeld, L.; Geiger, C.; Towhid, S.T.; Lang, F. Sensitization of erythrocytes to suicidal erythrocyte death following water deprivation. Kidney Blood Press Res. 2013, 37, 567-578.
64. Alzoubi, K.; Honisch, S.; Abed, M.; Lang, F. Triggering of suicidal erythrocyte death by penta-o-galloyl-beta-d-glucose. Toxins 2014, 6, 54-65.
65. Jilani, K.; Qadri, S.M.; Lang, F. Geldanamycin-induced phosphatidylserine translocation in the erythrocyte membrane. Cell. Physiol. Biochem. 2013, 32, 1600-1609.
66. Jilani, K.; Lang, F. Carmustine-induced phosphatidylserine translocation in the erythrocyte membrane. Toxins 2013, 5, 703-716.
67. Jilani, K.; Enkel, S.; Bissinger, R.; Almilaji, A.; Abed, M.; Lang, F. Fluoxetine induced suicidal erythrocyte death. Toxins 2013, 5, 1230-1243.
68. Bissinger, R.; Modicano, P.; Frauenfeld, L.; Lang, E.; Jacobi, J.; Faggio, C.; Lang, F. Estramustine-induced suicidal erythrocyte death. Cell. Physiol. Biochem. 2013, 32, 1426-1436.
69. Lupescu, A.; Jilani, K.; Zbidah, M.; Lang, F. Patulin-induced suicidal erythrocyte death. Cell. Physiol. Biochem. 2013, 32, 291-299.
70. Lupescu, A.; Bissinger, R.; Jilani, K.; Lang, F. Triggering of suicidal erythrocyte death by celecoxib. Toxins 2013, 5, 1543-1554.
71. Lang, E.; Modicano, P.; Arnold, M.; Bissinger, R.; Faggio, C.; Abed, M.; Lang, F. Effect of thioridazine on erythrocytes. Toxins 2013, 5, 1918-1931.
72. Harrison, H.E.; Bunting, H.; Ordway, N.K.; Albrink, W.S. The pathogenesis of the renal injury produced in the dog by hemoglobin or methemoglobin. J. Exp. Med. 1947, 86, 339-356.
73. Morad, S.A.; Cabot, M.C. Ceramide-orchestrated signalling in cancer cells. Nat. Rev. Cancer 2013, 13, 51-65.
74. Kunzelmann, K.; Nilius, B.; Owsianik, G.; Schreiber, R.; Ousingsawat, J.; Sirianant, L.; Wanitchakool, P.; Bevers, E.M.; Heemskerk, J.W. Molecular functions of anoctamin 6 (tmem16f): A chloride channel, cation channel, or phospholipid scramblase? Pflugers Arch. 2014, 466, 407-414.
75. Szteyn, K.; Schmid, E.; Nurbaeva, M.K.; Yang, W.; Munzer, P.; Kunzelmann, K.; Lang, F.; Shumilina, E. Expression and functional significance of the Ca(2+)-activated Cl(-) channel ano6 in dendritic cells. Cell. Physiol. Biochem. 2012, 30, 1319-1332.
76. Foller, M.; Bobbala, D.; Koka, S.; Huber, S.M.; Gulbins, E.; Lang, F. Suicide for survival-Death of infected erythrocytes as a host mechanism to survive malaria. Cell. Physiol. Biochem. 2009, 24, 133-140.
77. Duranton, C.; Huber, S.; Tanneur, V.; Lang, K.; Brand, V.; Sandu, C.; Lang, F. Electrophysiological properties of the plasmodium falciparum-induced cation conductance of human erythrocytes. Cell. Physiol. Biochem. 2003, 13, 189-198.
78. Kirk, K. Membrane transport in the malaria-infected erythrocyte. Physiol. Rev. 2001, 81, 495-537.
79. Ayi, K.; Giribaldi, G.; Skorokhod, A.; Schwarzer, E.; Prendergast, P.T.; Arese, P. 16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: A novel mechanism for antimalarial activity. Antimicrob. Agents Chemother. 2002, 46, 3180-3184.
80. Ayi, K.; Turrini, F.; Piga, A.; Arese, P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: A common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004, 104, 3364-3371.
81. Cappadoro, M.; Giribaldi, G.; O'Brien, E.; Turrini, F.; Mannu, F.; Ulliers, D.; Simula, G.; Luzzatto, L.; Arese, P. Early phagocytosis of glucose-6-phosphate dehydrogenase (g6pd)-deficient erythrocytes parasitized by plasmodium falciparum may explain malaria protection in g6pd deficiency. Blood 1998, 92, 2527-2534.
82. Koka, S.; Foller, M.; Lamprecht, G.; Boini, K.M.; Lang, C.; Huber, S.M.; Lang, F. Iron deficiency influences the course of malaria in plasmodium berghei infected mice. Biochem. Biophys. Res. Commun. 2007, 357, 608-614.
83. Koka, S.; Huber, S.M.; Boini, K.M.; Lang, C.; Foller, M.; Lang, F. Lead decreases parasitemia and enhances survival of plasmodium berghei-infected mice. Biochem. Biophys. Res. Commun. 2007, 363, 484-489.
84. Koka, S.; Lang, C.; Boini, K.M.; Bobbala, D.; Huber, S.M.; Lang, F. Influence of chlorpromazine on eryptosis, parasitemia and survival of plasmodium berghe infected mice. Cell. Physiol. Biochem. 2008, 22, 261-268.
85. Koka, S.; Lang, C.; Niemoeller, O.M.; Boini, K.M.; Nicolay, J.P.; Huber, S.M.; Lang, F. Influence of no synthase inhibitor l-name on parasitemia and survival of plasmodium berghei infected mice. Cell. Physiol. Biochem. 2008, 21, 481-488.
86. Andrews, D.A.; Low, P.S. Role of red blood cells in thrombosis. Curr. Opin. Hematol. 1999, 6, 76-82.
87. Borst, O.; Abed, M.; Alesutan, I.; Towhid, S.T.; Qadri, S.M.; Foller, M.; Gawaz, M.; Lang, F. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via cxcl16/sr-psox. Am. J. Physiol. Cell. Physiol. 2012, 302, C644-C651.
88. Closse, C.; Dachary-Prigent, J.; Boisseau, M.R. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br. J. Haematol. 1999, 107, 300-302.
89. Gallagher, P.G.; Chang, S.H.; Rettig, M.P.; Neely, J.E.; Hillery, C.A.; Smith, B.D.; Low, P.S. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003, 101, 4625-4627.
90. Pandolfi, A.; Di Pietro, N.; Sirolli, V.; Giardinelli, A.; Di Silvestre, S.; Amoroso, L.; Di Tomo, P.; Capani, F.; Consoli, A.; Bonomini, M. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J. Cell. Physiol. 2007, 213, 699-709.
91. Wood, B.L.; Gibson, D.F.; Tait, J.F. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical associations. Blood 1996, 88, 1873-1880.
92. Chung, S.M.; Bae, O.N.; Lim, K.M.; Noh, J.Y.; Lee, M.Y.; Jung, Y.S.; Chung, J.H. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 414-421.
93. Zwaal, R.F.; Comfurius, P.; Bevers, E.M. Surface exposure of phosphatidylserine in pathological cells. Cell. Mol. Life Sci. 2005, 62, 971-988.